<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2369">
  <stage>Registered</stage>
  <submitdate>20/05/2009</submitdate>
  <approvaldate>20/05/2009</approvaldate>
  <nctid>NCT00906646</nctid>
  <trial_identification>
    <studytitle>Preparation of Patients for Cardiac Surgery</studytitle>
    <scientifictitle>Preparation of Patients for Cardiac Surgery</scientifictitle>
    <utrn />
    <trialacronym>MPM</trialacronym>
    <secondaryid>91/04</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Coronary Artery Bypass Graft Surgery</healthcondition>
    <healthcondition>Cardiac Valve Surgery</healthcondition>
  </conditions>
  <interventions>
    <interventions>Other interventions - Metabolic therapy
Other interventions - Placebo

Experimental: Metabolic therapy - Metabolic therapy with antioxidants and cellular energisers

Placebo Comparator: Placebo - Placebo tablets


Other interventions: Metabolic therapy
Coenzyme Q10 - 100 mg tds Magnesium orotate - 400 mg tds Lipoic acid - 100 mg tds Omega-3 fatty acids - 300 mg (in 1 g fish oils) tds Selenium - 200 Âµg

Other interventions: Placebo
Placebo tablets

</interventions>
    <comparator />
    <control />
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Troponin release</outcome>
      <timepoint>24 hours after surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Length of hospital stay</outcome>
      <timepoint>1 month</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Rate of atrial fibrillation</outcome>
      <timepoint>2 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  patients undergoing elective coronary artery bypass graft (CABG) and/or valve surgery</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  urgent or emergency surgery

          -  NYHA class IV heart failure

          -  taken antioxidant supplements in the previous month</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2>The people administering the treatment/s</masking2>
    <masking3>The people assessing the outcomes</masking3>
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/04/2004</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>117</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2008</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>The Alfred Hospital - Melbourne</hospital>
    <postcode>3004 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Bayside Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Griffith University</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This was a prospective randomised trial of metabolic therapy including antioxidants and
      cellular energisers to determine whether this therapy could improve the results of cardiac
      surgery. The hypothesis was that the metabolic therapy could improve clinical recovery.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00906646</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Franklin L Rosenfeldt, MBBS, MD</name>
      <address>The Alfred</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>